Breast Cancer
US Focus Meeting 2026
📍 Sheraton Grand Nashville Downtown, 623 Union St, Nashville, TN 37219
🗓️ April 24 - 25, 2026
Last Year's Highlights
Dear Colleagues and Friends,
We are delighted to extend our warmest invitation to the Breast Cancer Focus Meeting 2026, to be held at on April 24 - 25, 2026.
Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing Breast Cancer research and patient treatment.
This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.
Chairs of Breast Cancer US Focus Meeting 2026:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
Virginia Kaklamani, MD
UT Health, San Antonio, TX
Supporters to be announced...
Interested in supporting this meeting? Get in contact:
cristina.anton@md-education.com
Agenda & Faculty
April 10, 2026 | Day 1
Session I: Advances in HER2-Positive Breast Cancer
Moderated by:
TBD
TBD
TBD
09:05 AM
Defining the New Standard of Care for HER2-Positive Metastatic Breast Cancer
Reshma L. Mahtani, MD
Baptist Health Wellness and Medical Complex, Plantation, FL
09:25 AM
Optimizing Treatment of Early-Stage HER2-Positive Breast Cancer
Ian Krop, MD
Yale School of Medicine, New Haven, CT
09:45 AM
Management of Brain Metastases in Metastatic Breast Cancer
AB
Andrew Brenner, MD
UT Health, San Antonio, TX
Session II: Optimizing Treatment of Triple-Negative Breast Cancer
Moderated by:
TBD
TBD
TBD
10:45 AM
Defining the New Standard of Care for Metastatic TNBC
NI
Neil Iyengar, MD
Emory Winship Cancer Institute, Atlanta, GA
11:05 AM
Optimizing Treatment for Early-Stage TNBC
JS
Joyce O’Shaughnessy, MD
Baylor Charles A. Sammons Cancer Center, Dallas, TX
11:25 AM
The Future of Immunotherapy
HM
Heather McArthur, MD
UT Southwestern Medical Center, Dallas, TX
Session III: Advances in Hormone Receptor-Positive Breast Cancer
Moderated by:
TBD
TBD
TBD
01:40 PM
Novel Endocrine Therapies
SS
Sarah Sammons, MD
Dana-Farber Cancer Institute, Boston, MA
02:00 PM
(Neo)Adjuvant Therapy for ER-Positive Breast Cancer
CM
Cynthia Ma, MD
Washington University School of Medicine,
St. Louis, MO
02:20 PM
Novel Targeted Agents for ER+ Metastatic Breast Cancer
SW
Seth Wander, MD
Massachusetts General Hospital, Boston, MA
Session IV: Innovations in Breast Surgery and Radiation
Moderated by:
TBD
TBD
TBD
04:05 PM
Endoscopic Breast Surgery: Is It the Future?
ESH
Eun-Sil Shelley Hwang, MD
Duke University, Durham, NC
04:25 PM
Optimizing Axillary Management for ER+ Breast Cancer: Is Less More?
AT
Alastair Thompson, MD
Baylor College of Medicine, Houston, TX
04:45 PM
Novel Techniques in Breast Radiation
RZ
Richard Zellars, MD
Royal Marsden NHS Foundation Trust,
London, UK
Saturday, April 25, 2026 | Day 2
Session V: Challenging Metastatic Disease Scenarios
Moderated by:
TBD
TBD
TBD
09:05 AM
Can We Cure Oligometastatic Disease?
PC
Pavani Chalasani, MD
The George Washington University,
Washington, DC
09:25 AM
Treatment of Leptomeningeal Disease
AB
Andrew Brenner, MD
UT Health, San Antonio, TX
09:45 AM
Treating for Molecular Progression
LP
Lajos Pusztai, MD
Yale School of Medicine, New Haven, CT
Session VI: Emerging Therapeutics and Special Perspectives
Moderated by:
TBD
TBD
TBD
10:45 AM
ADCs: Present and Future for “HER2- Negative” Breast Cancer
RN
Rita Nanda, MD
The University of Chicago Medicine, IL
11:05 AM
Role of Radioligand Imaging and Therapy in Breast Cancer
GU
Gary Ulaner, MD
Hoag Family Cancer Institute, Irvine, CA
11:25 AM
Lobular Breast Cancers: Should We Treat Them Distinctly?
SS
Sherry Shen, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Session VII: Breast Cancer Prevention and Risk Management
Moderated by:
TBD
TBD
TBD
01:40 PM
Updates on Breast Cancer Prevention
ET
Eleonora Teplinsky, MD
Valley Mount Sinai Comprehensive Cancer Care, Paramus, NJ
02:00 PM
Management of Genetically High-Risk Patients
MR
Mark Robson, MD
Memorial Sloan Kettering Cancer Center, New York, NY
02:20 PM
Role of Exercise and GLP-1 Agonists in Breast Cancer
SS
Saba Shaikh, MD
UT Health, San Antonio, TX
Session VIII: Survivorship, Toxicity Management, and Patient
Moderated by:
TBD
TBD
TBD
04:05 PM
Oncofertility
KL
Kate Lathrop, MD
UT Health, San Antonio, TX
04:25 PM
irAEs and Their Management
SG
Shipra Gandhi, MD
Emory Winship Cancer Institute, Atlanta, GA
04:45 PM
Beyond Survival: Optimizing Endpoints in Contemporary Cancer Trials
YS
Yu Shyr, MD
Vanderbilt University Medical Center,
Nashville, TN
Cristina Anton
Project Manager
How long has Cristina Anton been in the business?
Cristina Anton has been with MD Education since 2024.
About Cristina Anton
As a Senior Project Manager at MD Education’s Wigan office since 2022, I organise international medical conferences with a focus on breast cancer and inflammatory bowel disease (IBD). Originally from Romania, I have been based in the UK since 2015. My diverse background across sectors helps me deliver high-quality, impactful educational programs. I’m committed to excellence and continuous growth.
